litlas
Log inCreate account

William A. Craig

Active 1973–2019

Also published as
WILLIAM A. CRAIG
72
Papers
19,220
Citations
71
h-index
72
i10-index

Citations

Citations per year for William A. Craig1970: 1 citations1973: 2 citations1975: 4 citations1976: 10 citations1977: 19 citations1978: 10 citations1979: 3 citations1980: 9 citations1981: 12 citations1982: 7 citations1983: 10 citations1984: 18 citations1985: 8 citations1986: 8 citations1987: 14 citations1988: 26 citations1989: 10 citations1990: 32 citations1991: 51 citations1992: 30 citations1993: 16 citations1994: 22 citations1995: 35 citations1996: 44 citations1997: 39 citations1998: 72 citations1999: 62 citations2000: 77 citations2001: 123 citations2002: 98 citations2003: 159 citations2004: 148 citations2005: 132 citations2006: 145 citations2007: 139 citations2008: 90 citations2009: 129 citations2010: 121 citations2011: 116 citations2012: 129 citations2013: 121 citations2014: 113 citations2015: 122 citations2016: 105 citations2017: 90 citations2018: 65 citations2019: 354 citations2020: 278 citations2021: 219 citations2022: 164 citations2023: 117 citations2024: 179 citations2025: 56 citations1971–1972: no citations, so these years are not shown1974: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,373 citing papers, 32.9% of this breakdownUnited Kingdom: 243 citing papers, 5.8% of this breakdownAustralia: 234 citing papers, 5.6% of this breakdownFrance: 209 citing papers, 5% of this breakdownChina: 172 citing papers, 4.1% of this breakdownGermany: 167 citing papers, 4% of this breakdownNetherlands: 146 citing papers, 3.5% of this breakdownSpain: 141 citing papers, 3.4% of this breakdownCanada: 132 citing papers, 3.2% of this breakdownSwitzerland: 125 citing papers, 3% of this breakdownItaly: 110 citing papers, 2.6% of this breakdownBelgium: 103 citing papers, 2.5% of this breakdown
0%32.9%Other 24.4%

Institutions

Fields

  • Medicine66.5%
  • Biochemistry, Genetics and Molecular Biology19.1%
  • Immunology and Microbiology6.2%
  • Pharmacology, Toxicology and Pharmaceutics1.7%
  • Environmental Science1.2%
  • Veterinary0.9%
  • Other4.4%

Topics

  • Antibiotics Pharmacokinetics and Efficacy17.6%
  • Antibiotic Resistance in Bacteria11.5%
  • Antimicrobial Resistance in Staphylococcus8.1%
  • Pneumonia and Respiratory Infections5.5%
  • Bacterial Identification and Susceptibility Testing4.5%
  • Antibiotic Use and Resistance4.1%
  • Other48.7%

Coauthors

All papers

Open in search
  1. State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men

    Authors: William A. Craig - Clinical Infectious Diseases 1998 cited by 2,898

  2. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

    Authors: Michael J. Rybak, Ben M. Lomaestro, John C. Rotschafer, Robert C. Moellering, William A. Craig, Marianne Billeter, J. R. Dalovisio, Donald P. Levine - American Journal of Health-System Pharmacy 2008 cited by 1,794

  3. Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance

    Authors: Ryan T. Cirz, Jodie K. Chin, David R. Andes, Valérie de Crécy‐Lagard, William A. Craig, Floyd E. Romesberg - PLoS Biology 2005 cited by 582

  4. Protein Binding: Do We Ever Learn?

    Authors: Markus Zeitlinger, Hartmut Derendorf, Johan W. Mouton, Otto Cars, William A. Craig, David R. Andes, Ursula Theuretzbacher - Antimicrobial Agents and Chemotherapy 2011 cited by 247

  5. The Pharmacology of Meropenem, A New Carbapenem Antibiotic

    Authors: William A. Craig - Clinical Infectious Diseases 1997 cited by 180

  6. Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid

    Authors: William A. Craig - Infectious Disease Clinics of North America 2003 cited by 545

  7. In Vivo Pharmacodynamic Activity of Daptomycin

    Authors: Nasia Safdar, David R. Andes, William A. Craig - Antimicrobial Agents and Chemotherapy 2003 cited by 372

  8. Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model

    Authors: Bennett Vogelman, Sigurður Guðmundsson, J. E. Leggett, John Turnidge, Steven C. Ebert, William A. Craig - The Journal of Infectious Diseases 1988 cited by 721

  9. Animal model pharmacokinetics and pharmacodynamics: a critical review

    Authors: David R. Andes, William A. Craig - International Journal of Antimicrobial Agents 2002 cited by 411

  10. Therapeutic Monitoring of Vancomycin in Adults

    Authors: Michael J. Rybak, Ben M. Lomaestro, John C. Rotschafer, Robert C. Moellering, William A. Craig, Marianne Billeter, J. R. Dalovisio, Donald P. Levine - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2009 cited by 399

  11. Tissue concentrations: do we ever learn?

    Authors: Johan W. Mouton, Ursula Theuretzbacher, William A. Craig, Paul M. Tulkens, H. Derendorf, Otto Cars - Journal of Antimicrobial Chemotherapy 2007 cited by 340

  12. In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

    Authors: David R. Andes, William A. Craig - Antimicrobial Agents and Chemotherapy 2007 cited by 115

  13. Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia

    Authors: C. Pulcini, Karen Bush, William A. Craig, Jens Kjølseth Møller, M. Lindsay Grayson, Johan W. Mouton, John Turnidge, Stephan Harbarth, Inge C. Gyssens, the ESCMID Study Group for Antibiotic Policies - Clinical Infectious Diseases 2011 cited by 103

  14. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

    Authors: David M. Shlaes, Dale N. Gerding, Joseph F. John, William A. Craig, Donald L. Bornstein, Robert A. Duncan, Mark R. Eckman, William Farrer, William H. Greene, Víctor Lorian, Stuart B. Levy, John E. McGowan, Sindy M. Paul, Joel Ruskin, Fred C. Tenover, Chatrchai Watanakunakorn - Clinical Infectious Diseases 1997 cited by 783

  15. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

    Authors: William A. Craig - Diagnostic Microbiology and Infectious Disease 1995 cited by 614

  16. In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)

    Authors: David R. Andes, M L van Ogtrop, Jie Peng, William A. Craig - Antimicrobial Agents and Chemotherapy 2002 cited by 282

  17. In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria

    Authors: M L van Ogtrop, David R. Andes, T. Stamstad, Boyd Conklin, Jason Weiss, William A. Craig, Ómar Vesga - Antimicrobial Agents and Chemotherapy 2000 cited by 178

  18. In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models

    Authors: William A. Craig, David R. Andes - Antimicrobial Agents and Chemotherapy 2008 cited by 89

  19. Use of Antibiotics

    Authors: Calvin M. Kunin, THELMA TUPASI, WILLIAM A. CRAIG - Annals of Internal Medicine 1973 cited by 362

  20. Related Clones Containing SCC mec Type IV Predominate among Clinically Significant Staphylococcus epidermidis Isolates

    Authors: Hilmar Wisplinghoff, Adriana E. Rosato, Mark C. Enright, Michael J. Noto, William A. Craig, Gordon L. Archer - Antimicrobial Agents and Chemotherapy 2003 cited by 199

  21. The postantibiotic effect

    Authors: William A. Craig - Clinical Microbiology Newsletter 1991 cited by 142

  22. In Vivo Activities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum β-Lactamases, in the Thighs of Neutropenic Mice

    Authors: William A. Craig, David R. Andes - Antimicrobial Agents and Chemotherapy 2012 cited by 131

  23. Optimizing Aminoglycoside Use

    Authors: William A. Craig - Critical Care Clinics 2010 cited by 103

  24. In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model

    Authors: David R. Andes, William A. Craig, Line Anker Nielsen, H. H. Kristensen - Antimicrobial Agents and Chemotherapy 2009 cited by 80